Open Source The Coronavirus Research

The intended beneficiaries of innovations protected by patents are The People, not the patent owners.

There is an apparent international tussle over the rights to the work product produced by the researchers that are on the hunt for a vaccine for the coronavirus. And I’ve noticed some curious behavior exhibited by the Trump Administration as a participant in that tussle. It has been reported that Trump was seeking first dibs or exclusive access to a vaccine in the works at a company in Germany. From…